The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Sprt Regulatory News (SIS)

Share Price Information for Science Sprt (SIS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.00
Bid: 18.50
Ask: 19.50
Change: 0.25 (1.33%)
Spread: 1.00 (5.405%)
Open: 19.00
High: 19.00
Low: 19.00
Prev. Close: 18.75
SIS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Extends Partnership with INEOS Grenadiers

10 May 2021 07:00

RNS Number : 0031Y
Science in Sport PLC
10 May 2021
 

10 May 2021

AIM: SIS

Science in Sport plc

("Science in Sport" or "the Company")

 

Extends Partnership with British Professional Cycling Team, INEOS Grenadiers

 

Science in Sport, the premium performance nutrition company serving elite athletes, sports enthusiasts and the gym lifestyle community, is pleased to announce that it has signed a three year extension to its partnership with INEOS Grenadiers, the British professional cycling team, ranked as one of the world's most successful cycling teams. 

 

Under the terms of the partnership, Science in Sport will advise and manage INEOS Grenadiers' nutrition strategy, with the Company's expert nutritionists embedded in the performance staff of INEOS Grenadiers. The new agreement continues a successful five year relationship, which has supported INEOS Grenadiers's seven 'Grand Tours' cycling victories. 

 

The embedding of experts within elite sports teams is part of the Company's Performance Solutions nutrition service, which is designed to elevate athletes to the next level of performance. The approach, which is science-led, results in the development of highly tailored solutions that cater both for the needs of individuals and the wider team. Significantly, it also includes the development of new products by the Company.

 

Science in Sport is widely considered to be the leading performance nutrition company globally in the areas of product innovation and product quality. It undertakes category-leading research from its laboratory based at Liverpool John Moores University, developing new products in collaboration with its partner athletes and teams. Science in Sport has a long association with British cycling, and fuelled Chris Froome's high profile win at the 2018 Giro d'Italia with a then trial product, "Beta Fuel", which has since become a commercial success. British cyclist Tao Geoghegan Hart's Giro d'Italia win in 2020 was similarly supported by a new product, which is to be launched shortly to the public, ahead of the annual Tour de France race in early June.

 

Sir Dave Brailsford, Team Principal of INEOS Grenadiers, said,

 

"Nutrition is a vital part of elite sport and in Science in Sport we have a partner who shares our ethos of continual innovation. Together, we've been using world-leading science to deliver a performance-first approach and build upon a five year relationship that has seen cutting-edge products fuel our Team to win the biggest races in the sport. We're looking forward to achieving even more with Science in Sport in the future."

 

Stephen Moon, CEO of Science in Sport plc, said,

 

"We are very pleased to be extending our partnership with INEOS Grenadiers, which has worked extremely successfully over the past five years. We are world-leaders in our sector for science-led product innovation, and our partnerships with elite sport teams and athletes help to drive their success and to highlight the quality and integrity of our products.

 

"We look forward to continuing to innovate with Britain's best sports teams and fuel many more Grand Tour cycling wins for INEOS Grenadiers."

 

Science in Sport plc

T: 020 7400 3700

Stephen Moon, CEO

James Simpson, CFO

KTZ Communications

T: 020 3178 6378

Katie Tzouliadis, Dan Mahoney

 

About Science in Sport plc

www.sisplc.com

 

Headquartered in London, Science in Sport plc is a leading sports nutrition business that develops, manufactures and markets innovative nutrition products for professional athletes, sports and fitness enthusiasts and the gym lifestyle community. The Company has two highly regarded brands, PhD Nutrition, a premium active-nutrition brand targeting the gym lifestyle community, and SiS, a leading endurance nutrition brand among elite athletes and professional sports teams.

 

The two brands are sold internationally through the Company's phd.com and scienceinsport.com digital platforms, third-party online sites, including Amazon and Tmall, and an extensive retail distribution in the UK and internationally, including major supermarkets, high street chains and specialist sports retailers. This omnichannel footprint enables the Company to address the full breadth of the sports nutrition market, forecast to be £13 billion worldwide by 2023.

 

PhD is one of the UK's leading active nutrition brands with a reputation for high quality and product innovation. The brand has grown rapidly, based on its core protein powders, since its launch in 2005. The range now comprises powders, bars and supplements, including the high protein, low sugar range, PhD Smart. PhD brand ambassadors include leading fitness influencers Ross Edgley and Obi Vincent. The PhD brand is an official partner to the Tough Mudder Challenge and Race Series.

 

SiS, founded in 1992, has a core range comprising gels, powders and bars focused on energy, hydration and recovery. SiS is the official sports nutrition supplier to many professional teams and organisations, including INEOS Grenadiers Cycling Team, Team INEOS UK (America's Cup Team) and Manchester United Football Club. SiS supplies more than 100 professional football clubs in the UK, Europe and the USA and is Performance Research Partner to the English Football Association.

 

For further information, please visit phd.com and scienceinsport.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUKAARARUVRUR
Date   Source Headline
10th Mar 20227:00 amRNSInvestor Presentation
22nd Feb 202211:27 amRNSTR-1: Notification of Major Holdings
22nd Feb 202211:24 amRNSTR-1: Notification of Major Holdings
24th Jan 20225:49 pmRNSHolding(s) in Company
19th Jan 20227:00 amRNSTrading Update
5th Jan 20227:00 amRNSAppointment of Joint Broker
4th Jan 20224:51 pmRNSHolding(s) in Company
7th Oct 20213:12 pmRNSHolding(s) in Company
29th Sep 20217:00 amRNSPartnership with Milwaukee Bucks
15th Sep 20217:00 amRNSInterim Results
9th Sep 20217:00 amRNSInvestor Presentation
2nd Aug 20217:00 amRNSNew PhD Nutrition 'Life' Range
19th Jul 20217:00 amRNSLaunch of new category-leading product range
14th Jul 20217:00 amRNSHalf Year Trading Update
24th Jun 20213:44 pmRNSResult of AGM
22nd Jun 20213:10 pmRNSHolding(s) in Company
21st Jun 202110:57 amRNSHolding(s) in Company
20th May 20217:00 amRNSNotice of AGM
19th May 202112:59 pmRNSNotification of Major Holdings
10th May 20215:10 pmRNSPDMR Share Purchases
10th May 20217:00 amRNSExtends Partnership with INEOS Grenadiers
28th Apr 202111:01 amRNSPDMR Share Purchases
18th Mar 20212:34 pmRNSNotification of Major Holdings
17th Mar 20217:00 amRNSFinal Results
11th Mar 20217:00 amRNSInvestor Presentation
5th Feb 202112:50 pmRNSNotification of Major Holdings
1st Feb 20211:59 pmRNSHolding(s) in Company
28th Jan 20217:00 amRNSCapital Markets Day
15th Jan 20212:06 pmRNSSecond Price Monitoring Extn
15th Jan 20212:00 pmRNSPrice Monitoring Extension
14th Jan 20217:00 amRNSPre-Close Trading Update
4th Jan 20217:00 amRNSDates for Investor Presentation and Trading Update
4th Dec 20208:52 amRNSNotification of Major Holdings
3rd Dec 202012:16 pmRNSNotification of Major Holdings
3rd Dec 20209:05 amRNSSecond Price Monitoring Extn
3rd Dec 20209:00 amRNSPrice Monitoring Extension
2nd Dec 20207:00 amRNSTrading Update
19th Nov 20207:00 amRNSIntroduction of Recyclable Packaging Range
17th Nov 202011:52 amRNSNotification of Major Holdings
3rd Nov 20204:17 pmRNSHolding(s) in Company
5th Oct 20207:00 amRNSPDMR Share Purchases
1st Oct 20207:00 amRNSGrant of Options
21st Sep 20202:05 pmRNSSecond Price Monitoring Extn
21st Sep 20202:00 pmRNSPrice Monitoring Extension
21st Sep 202011:06 amRNSSecond Price Monitoring Extn
21st Sep 202011:00 amRNSPrice Monitoring Extension
21st Sep 20209:05 amRNSSecond Price Monitoring Extn
21st Sep 20209:00 amRNSPrice Monitoring Extension
16th Sep 20207:00 amRNSInterim Results
10th Sep 20204:39 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.